Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 3:58 pm Sale | 2024-12-31 | 13G | PolyPid Ltd. PYPD | Rosalind Advisors Inc. | 4,081,088 9.900% | -4,500 (-0.11%) | Filing History |
| 2025-02-13 1:41 pm Purchase | 2025-02-13 | 13G | Trevi Therapeutics, Inc. TRVI | Rosalind Advisors Inc. | 1,062,500 1.200% | 312,500 (+41.67%) | Filing History |
| 2025-02-13 12:50 pm Unchanged | 2024-12-31 | 13G | Spruce Biosciences, Inc. SPRB | Rosalind Advisors Inc. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-02-12 11:29 am Purchase | 2024-12-31 | 13G | Biofrontera Inc. BFRI | Rosalind Advisors Inc. | 9,962,649 9.900% | 2,765,873 (+38.43%) | Filing History |
| 2025-02-11 4:18 pm Purchase | 2024-12-31 | 13G | MediWound Ltd. MDWD | Rosalind Advisors Inc. | 791,315 7.200% | 163,265 (+26.00%) | Filing History |
| 2025-02-10 4:14 pm Purchase | 2024-12-31 | 13G | PolyPid Ltd. PYPD | Rosalind Advisors Inc. | 4,085,588 9.900% | 3,399,416 (+495.42%) | Filing History |
| 2025-02-10 4:03 pm Purchase | 2024-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Rosalind Advisors Inc. | 715,231 9.900% | 250,554 (+53.92%) | Filing History |
| 2025-02-07 11:58 am Purchase | 2024-12-31 | 13G | OptiNose, Inc. OPTN | Rosalind Advisors Inc. | 964,587 8.700% | 964,587 (New Position) | Filing History |
| 2025-02-07 11:24 am Purchase | 2024-12-31 | 13G | InspireMD, Inc. NSPR | Rosalind Advisors Inc. | 9,933,964 9.900% | 2,495,783 (+33.55%) | Filing History |
| 2025-02-04 3:35 pm Purchase | 2024-12-31 | 13G | Myomo, Inc. MYO | Rosalind Advisors Inc. | 7,574,330 9.900% | 2,998,945 (+65.55%) | Filing History |
| 2025-02-03 4:57 pm Purchase | 2024-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors Inc. | 7,472,745 9.900% | 502,320 (+7.21%) | Filing History |
| 2025-01-27 4:02 pm Purchase | 2024-12-23 | 13D | Delcath Systems, Inc. DCTH | Rosalind Advisors Inc. | 6,659,993 9.900% | 3,896,525 (+141.00%) | Filing History |
| 2024-12-02 11:53 am Unchanged | 2024-11-12 | 13D | NeurAxis, Inc. NRXS | Rosalind Advisors Inc. | 2,100,840 9.900% | 0 (Unchanged) | Filing History |
| 2024-12-02 09:57 am Purchase | 2024-11-12 | 13G | NeurAxis, Inc. NRXS | Rosalind Advisors Inc. | 2,100,840 9.900% | 2,100,840 (New Position) | Filing History |
| 2024-11-15 10:33 am Unchanged | 2024-10-30 | 13D | Delcath Systems, Inc. DCTH | Rosalind Advisors Inc. | 2,763,468 9.900% | 0 (Unchanged) | Filing History |
| 2024-11-14 9:46 pm Unchanged | 2024-10-30 | 13D | Delcath Systems, Inc. DCTH | Rosalind Advisors Inc. | 2,763,468 9.900% | 0 (Unchanged) | Filing History |
| 2024-11-06 10:48 am Sale | 2024-10-31 | 13G | Biofrontera Inc. BFRI | Rosalind Advisors Inc. | 7,196,776 6.900% | -675,713 (-8.58%) | Filing History |
| 2024-10-28 4:02 pm Unchanged | 2024-09-30 | 13G | InspireMD, Inc. NSPR | Rosalind Advisors Inc. | 7,438,181 9.800% | 0 (Unchanged) | Filing History |
| 2024-10-23 3:14 pm Unchanged | 2024-09-30 | 13G | Biofrontera Inc. BFRI | Rosalind Advisors Inc. | 7,872,489 8.900% | 0 (Unchanged) | Filing History |
| 2024-10-23 3:05 pm Unchanged | 2024-09-30 | 13G | PolyPid Ltd. PYPD | Rosalind Advisors Inc. | 686,172 9.900% | 0 (Unchanged) | Filing History |